학술논문

Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
Document Type
Article
Source
In: The Lancet Oncology. (The Lancet Oncology, July 2024, 25(7):853-864)
Subject
Language
English
ISSN
14745488
14702045